HCV NEXT September Issue - Creating a world with “NOhep” by 2030

"HCV Next" features cutting edge news on the latest HCV research developments. With in-depth articles on a range of topics; diagnosis, hepatitis c treatment regimens, side effects, drug/drug interaction, guidelines, practice management issues, to name a few.

The following articles appeared in the September print edition of HCV NEXT, available online @ Healio.

Table of Contents

Creating a world with “NOhep” by 2030

5 Questions
A Conversation With Ravi Jhaveri, MD, FIDSA, FPIDS

Cover Story
Taking the Next Steps in the Global Pledge for Hepatitis Eradication

Editorial
Common Global Languagemay Lead to Progress on Hepatitis Eradication

Feature
Experts Call for Continued Focus on Genetics Genomics in DAA Era

In the Journals Plus
Sharing Snorting Utensils for Drug Use may Increase HCV Transmission

Meeting News Coverage
HCV not Associated With Increase in HIV Viral Load Among Adults With HIV

Trend Watch
TREKtx Acquires Lomibuvir, Merimepodib

MPP Signs Generic Manufacturing Licenses for HIV, HCV Drugs

AASLD/IDSA Update HCV Guidance

European Commission Approves Epclusa for all HCV Genotypes

European Commission Approves Zepatier for HCV Genotypes 1, 4

Begin here...